ADPT(Adaptive Biotechnologies Corporation) · 财务报表

ADPT(Adaptive Biotechnologies Corporation) 的财务报表:医疗保健,诊断与研究。数据来自 SEC 公开申报与市场行情,不构成投资建议。

近年年度财务(SEC XBRL)
科目FY 截至 2021-12-31FY 截至 2022-12-31FY 截至 2023-12-31FY 截至 2024-12-31FY 截至 2025-12-31
营业收入$154.34M$185.31M$170.28M$178.96M$276.98M
毛利润$105.04M$127.40M$94.72M$106.88M$205.62M
营业利润−$208.97M−$200.19M−$227.03M−$162.55M−$57.12M
净利润−$207.28M−$200.19M−$225.25M−$159.49M−$59.50M
经营现金流−$192.73M−$183.94M−$156.32M−$95.21M−$45.99M
自由现金流−$254.47M−$200.29M−$167.02M−$98.88M−$48.95M
摊薄每股收益$-1.48$-1.40$-1.56$-1.08$-0.39

Adaptive Biotechnologies Corporation ADPT